InsideTrading SEC Form 4 insider trades

Stocks

ALLO Allogene Therapeutics, Inc.

Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $289.8M

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $2.1M, sold $442.6K 2022-Q2: bought $0, sold $225.1K 2022-Q3: bought $0, sold $298.1K 2022-Q4: bought $0, sold $42.2K 2023-Q1: bought $0, sold $41.7K 2023-Q2: bought $0, sold $0 2023-Q3: bought $0, sold $42.9K 2023-Q4: bought $0, sold $50.3K 2024-Q1: bought $684, sold $0 2024-Q2: bought $5.0M, sold $68.7K 2024-Q3: bought $0, sold $0 2024-Q4: bought $0, sold $39.8K 2025-Q1: bought $0, sold $336.1K 2025-Q2: bought $0, sold $65.9K 2025-Q3: bought $0, sold $0 2025-Q4: bought $0, sold $47.3K 2026-Q1: bought $0, sold $534.1K 2026-Q2: bought $0, sold $22.1K 2026-Q3: bought $0, sold $63.0K 2026-Q4: bought $0, sold $48.7K
Bought, above the line (largest quarter $5.0M) Sold, below the line (largest quarter $534.1K)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$2.1M$442.6K
2022-Q2$0$225.1K
2022-Q3$0$298.1K
2022-Q4$0$42.2K
2023-Q1$0$41.7K
2023-Q2$0$0
2023-Q3$0$42.9K
2023-Q4$0$50.3K
2024-Q1$684$0
2024-Q2$5.0M$68.7K
2024-Q3$0$0
2024-Q4$0$39.8K
2025-Q1$0$336.1K
2025-Q2$0$65.9K
2025-Q3$0$0
2025-Q4$0$47.3K
2026-Q1$0$534.1K
2026-Q2$0$22.1K
2026-Q3$0$63.0K
2026-Q4$0$48.7K

Insider activity

Download CSV Up to 5,000 rows
Bought$7.1M4 buy days
Sold$2.4M48 sell days
Net insider flow+$4.8Mnet buying · 5 years
Latest trade2026-10-21Parker Geoffrey M.
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2026-10-21 Sell Parker Geoffrey M. CFO 36,342 $1.34 $48.7K 1
2026-08-21 Sell Douglas Earl Martin General counsel 29,697 $2.12 $63.0K 1
2026-04-21 Sell Yoshiyama Annie EVP / SVP 9,586 $2.31 $22.1K 1
2026-03-31 Sell Beneski Benjamin Machinas Other C-suite 2,867 $2.50 $7.2K 1
2026-03-16 Sell Chang David D CEO 47,763 $2.47 $118.0K 1
2026-03-16 Sell Beneski Benjamin Machinas Other C-suite 4,835 $2.47 $11.9K 1
2026-03-02 Sell Beneski Benjamin Machinas Other C-suite 7,132 $2.60 $18.5K 1
2026-02-02 Sell Chang David D CEO 95,269 $1.80 $171.5K 1
2026-02-02 Sell Roberts Zachary EVP / SVP 35,700 $1.77 $63.2K 1
2026-02-02 Sell Parker Geoffrey M. CFO 24,001 $1.76 $42.2K 1
2026-02-02 Sell Douglas Earl Martin General counsel 22,900 $1.76 $40.3K 1
2026-02-02 Sell Beneski Benjamin Machinas Other C-suite 7,549 $1.73 $13.1K 1
2026-02-02 Sell Yoshiyama Annie EVP / SVP 4,167 $1.72 $7.2K 1
2026-01-21 Sell Roberts Zachary EVP / SVP 26,269 $1.56 $41.0K 1
2025-11-17 Sell Beneski Benjamin Machinas Other C-suite 786 $1.22 $959 1
2025-10-21 Sell Parker Geoffrey M. CFO 36,744 $1.26 $46.3K 1
2025-06-10 Sell MESSEMER DEBORAH M. Director 36,885 $1.42 $52.4K 1
2025-04-21 Sell Yoshiyama Annie EVP / SVP 9,601 $1.41 $13.5K 1
2025-03-14 Sell Chang David D CEO 46,668 $1.96 $91.5K 1
2025-03-14 Sell Beneski Benjamin Machinas Other C-suite 5,488 $1.98 $10.9K 1
2025-02-18 Sell MESSEMER DEBORAH M. Director 13,313 $2.43 $32.4K 1
2025-02-03 Sell Chang David D CEO 46,003 $1.68 $77.3K 1
2025-02-03 Sell Roberts Zachary EVP / SVP 18,832 $1.70 $32.0K 1
2025-02-03 Sell MOORE TIMOTHY L. Other C-suite 14,746 $1.71 $25.2K 1
2025-02-03 Sell Douglas Earl Martin General counsel 6,404 $1.71 $11.0K 1
2025-02-03 Sell Parker Geoffrey M. CFO 4,361 $1.73 $7.5K 1
2025-01-21 Sell Roberts Zachary EVP / SVP 27,199 $1.78 $48.4K 1
2024-12-09 Sell MESSEMER DEBORAH M. Director 9,136 $2.18 $19.9K 1
2024-12-05 Sell Humer Franz B Director 9,221 $2.16 $19.9K 1
2024-06-18 Sell MESSEMER DEBORAH M. Director 18,641 $2.28 $42.5K 1
2024-05-30 Sell Humer Franz B Director 11,200 $2.34 $26.2K 1
2024-05-16 Buy Belldegrun Arie Director 1,724,137 $2.90 $5.0M 1
2024-01-30 Buy Parker Geoffrey M. CFO 190 $3.60 $684 1
2023-12-18 Sell MESSEMER DEBORAH M. Director 18,640 $2.70 $50.3K 1
2023-08-07 Sell Mayo Stephen Director 10,000 $4.29 $42.9K 1
2023-02-13 Sell Bhavnagri Veer General counsel 3,000 $6.85 $20.6K 1
2023-01-17 Sell Bhavnagri Veer General counsel 3,000 $7.04 $21.1K 1
2022-12-15 Sell Bhavnagri Veer General counsel 5,602 $7.53 $42.2K 1
2022-08-12 Sell WITTE OWEN N. Director 5,000 $17.25 $86.2K 1
2022-08-11 Sell WITTE OWEN N. Director 10,000 $16.50 $165.0K 1
2022-08-02 Sell Amado Rafael Other C-suite 2,000 $11.97 $23.9K 1
2022-07-05 Sell Amado Rafael Other C-suite 2,000 $11.44 $22.9K 1
2022-06-22 Sell WITTE OWEN N. Director 10,000 $11.76 $117.6K 1
2022-06-21 Sell Amado Rafael Other C-suite 2,000 $11.18 $22.4K 1
2022-05-19 Sell Amado Rafael Other C-suite 11,500 $7.40 $85.1K 1
2022-03-15 Sell Chang David D CEO 23,648 $7.65 $180.9K 1
2022-03-15 Sell SCHMIDT ERIC THOMAS CFO 11,469 $7.63 $87.5K 1
2022-03-15 Sell Bhavnagri Veer General counsel 8,849 $7.68 $68.0K 1
2022-03-15 Sell MOORE ALISON Other C-suite 8,698 $7.63 $66.4K 1
2022-03-15 Sell Amado Rafael Other C-suite 5,169 $7.71 $39.9K 1
2022-01-12 Buy Belldegrun Arie Director 155,039 $12.60 $2.0M 1
2022-01-12 Buy Kazam Joshua A Director 15,000 $12.60 $189.0K 1

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
Belldegrun Arie Director $7.0M $0 2024-05-16
Chang David D CEO $0 $639.1K 2026-03-16
WITTE OWEN N. Director $0 $368.8K 2022-08-12
MESSEMER DEBORAH M. Director $0 $197.5K 2025-06-10
Amado Rafael Other C-suite $0 $194.1K 2022-08-02
Kazam Joshua A Director $189.0K $0 2022-01-12
Roberts Zachary EVP / SVP $0 $184.6K 2026-02-02
Bhavnagri Veer General counsel $0 $151.8K 2023-02-13
Parker Geoffrey M. CFO $684 $144.8K 2026-10-21
Douglas Earl Martin General counsel $0 $114.2K 2026-08-21
SCHMIDT ERIC THOMAS CFO $0 $87.5K 2022-03-15
MOORE ALISON Other C-suite $0 $66.4K 2022-03-15
Beneski Benjamin Machinas Other C-suite $0 $62.5K 2026-03-31
Humer Franz B Director $0 $46.1K 2024-12-05
Mayo Stephen Director $0 $42.9K 2023-08-07
Yoshiyama Annie EVP / SVP $0 $42.8K 2026-04-21
MOORE TIMOTHY L. Other C-suite $0 $25.2K 2025-02-03

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

Buying clusters at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2018-10-15 6 $18.8M 56 +27.4% (+30.3% raw)+26.3% (+27.4% raw)+15.4% (+22.4% raw) closed

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.